In numerous trials, the product dioxychlor (active ingredient chlorine dioxide) was further developed and optimized both in its form of manufacture and in its effect in close cooperation between researchers at the Bradford Research Institute and Stanford University, the National Cancer Institute (NCI) and the Mayo Clinics. The effectiveness of this oxygen preparation has been proven with over 50,000 infusions for various indications worldwide. Why do they never report on this large-scale clinical trial of intravenous chlorine dioxide and its successes? Maybe so they can continue to claim there are no clinical studies on chlorine dioxide?

Facts:

– Study dioxychlor